Logo Image
|Articles|June 10, 2014

MedTrials Participates in ACRP Certification Supporting Partner Program

MedTrials is the latest participant in the Association of Clinical Research Professionals' Certification Supporting Partner Program.

MedTrials, a contract research organization, is the latest participant in the Association of Clinical Research Professionals' (ACRP) Certification Supporting Partner Program. The ACRP Certification Supporting Partner Program provides employees at partnering organizations with discounted Certification fees and exam preparation resources. Aggregate performance data is provided to partnering organizations to assist in identifying knowledge gaps of clinical research staff. The ACRP Certification Supporting Partner Program allows organizations to financially support and actively encourage eligible employees to pursue ACRP Certification and Maintenance of Certification through ACRP's Certified Clinical Research Associate (CCRA®), Certified Clinical Research Coordinator (CCRC®), and Certified Physician Investigator (CPI®) programs.

Read the full release here.

Related to this article

View more
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.
Read more
What the Epilepsy Community Has Taught Us About Trial Feasibility
What the Epilepsy Community Has Taught Us About Trial Feasibility
In this video interview, Amélie Lothe, global medical community head for rare epilepsies at UCB Pharma, shares what she has learned firsthand from families living with Dravet syndrome and CDKL5 deficiency disorder about what makes trial participation possible—and what makes it not.
Read more